Trial Profile

A Pilot Phase 2a, Multicentre, Open, Proof-of-concept Study on the Safety and the Efficacy of Allogeneic Osteoblastic Cells (ALLOB) Implantation in Lumbar Spinal Fusion

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Allogeneic osteoblastic cell therapy Bone Therapeutics (Primary)
Indications Intervertebral disc degeneration
Focus Adverse reactions; Proof of concept; Therapeutic Use
Sponsors BioSenic; Bone Therapeutics

Most Recent Events

28 Jan 2021 Status changed from active, no longer recruiting to completed.
14 Oct 2020 Results (24-month follow-up results) presented in a Bone Therapeutics media release.
22 Jan 2020 According to a Bone Therapeutics media release, two-year follow up data is expected in the second half of 2020 following the successful completion of the 12-months period.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com